Joseph E. Payne’s Role in Arcturus Therapeutics’ Expansion into RNA-Based Treatments for Rare and Orphan Diseases
The biotech industry has traditionally focused on common diseases with large patient groups, partly due to the financial incentives matching broader marketplace demand. But in recent years, there has been …
Joseph E. Payne’s Role in Arcturus Therapeutics’ Expansion into RNA-Based Treatments for Rare and Orphan Diseases Read More